Noxopharm Ltd (NOX) — Cash Flow-to-Debt Ratio
Noxopharm Ltd (NOX) has a Cash Flow-to-Debt Ratio of -0.46x as of December 2025, meaning its operating cash flow of AU$-2.71 Million could theoretically repay 0% of its total liabilities (AU$5.88 Million) in one year. See Noxopharm Ltd (NOX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Noxopharm Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Noxopharm Ltd across 10 annual periods. Also explore NOX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Noxopharm Ltd (2016–2025)
Year-by-year debt coverage analysis for Noxopharm Ltd. For market capitalisation and broader financial context, see how much is Noxopharm Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.50x | AU$-5.82 Million | AU$3.89 Million | ▼ -181.9% |
| 2024 | -0.53x | AU$-684.31K | AU$1.29 Million | ▲ +94.9% |
| 2023 | -10.37x | AU$-10.95 Million | AU$1.06 Million | ▼ -87.0% |
| 2022 | -5.55x | AU$-13.73 Million | AU$2.48 Million | ▼ -343.6% |
| 2021 | -1.25x | AU$-8.85 Million | AU$7.08 Million | ▲ +19.2% |
| 2020 | -1.55x | AU$-11.14 Million | AU$7.19 Million | ▲ +8.9% |
| 2019 | -1.70x | AU$-9.78 Million | AU$5.75 Million | ▲ +17.6% |
| 2018 | -2.06x | AU$-9.08 Million | AU$4.40 Million | ▲ +74.5% |
| 2017 | -8.08x | AU$-2.92 Million | AU$361.04K | ▼ -284.8% |
| 2016 | -2.10x | AU$-549.72K | AU$261.72K | — |